Successful Empirical Treatment of Intravenous Immune Globulin in Recent-Onset Idiopathic Dilated Cardiomyopathy: A Case Report.
- Author:
Hyun Soo KIM
1
;
Keum Nam RIM
;
Hyun Jong SHIN
;
Sang Pyo LEE
;
Sang Bong AHN
;
Yong Gu LEE
;
Young Chul LEE
;
Na Rae HA
;
Sun Joo CHANG
;
Jin Ho SHIN
Author Information
1. Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. jhs2003@hanyang.ac.kr
- Publication Type:Case Report
- Keywords:
Acute myocarditis;
Idiopathic dilated cardiomyopathy;
Immunoglobulin
- MeSH:
Adult;
Cardiomyopathy, Dilated*;
Death, Sudden, Cardiac;
Female;
Heart Failure;
Humans;
Immunoglobulins;
Immunoglobulins, Intravenous*
- From:The Korean Journal of Critical Care Medicine
2007;22(2):96-100
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Intravenous immunoglobulin (IVIG) therapy has been introduced to idiopathic dilated cardiomyopathy due to their antiviral and anti-inflammatory effects. But each study reported conflicting result and treatment regimen has not been clearly established. We experienced a case of 28-year-old woman with idiopathic dilated cardiomyopathy with severely depressed cardiac function. Its onset time was obvious within 1 month. Despite of conservative treatment of heart failure, sudden cardiac arrest was developed. We tried IVIG therapy, and her symptoms and cardiac function were improved after IVIG treatment.
